XML 79 R40.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 6 Months Ended
Jan. 31, 2023
USD ($)
$ / shares
shares
Feb. 28, 2023
shares
Jan. 31, 2023
USD ($)
$ / shares
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2022
shares
Dec. 31, 2022
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Public offering (in shares) 17,500,000          
Common stock, par value (in dollars per share) | $ / shares $ 0.001   $ 0.001 $ 0.001   $ 0.001
Offering share amount maximum (in dollars per share) | $ / shares $ 10.00   $ 10.00      
Public offering, option to purchase additional shares, period 30 days          
Public offering, option to purchase additional shares (in shares) 2,600,000          
Percentage commission of gross proceeds on sale of common stock under at-the-market offering 5.75%          
Proceeds from issuance of stock | $ $ 189.7          
Offering expenses | $     $ 0.5      
Dividend yield       0.00%    
Time Based Restricted Stock Units PSU            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Amount eligible to vest upon achievement of goal       2    
Shelf Offering            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares issued (in shares) 20,100,000          
2020 Plan, Inducement Plan, And The Omniome Plan            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Common stock remain available for issuance (in shares)       12,200,000    
ESPP            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares issued (in shares)       1,052,908 1,316,923  
Additional common stock reserved for issuance (in shares)   4,000,000        
Common stock remain available for issuance (in shares)       12,900,000    
Dividend yield       0.00% 0.00%